A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA)

By sjmartinez • February 15, 2023

Khanna D, Denton CP, Furst DE, Mayes MD, Matucci-Cerinic M, Smith V, de Vries D, Ford P, Bauer Y, Randall MJ, Ebrahimpoor M, Kupcsik L, Stiers PJ, Deberdt L, Prasad N, Lim S, Pujuguet P, Ahmed S. A 24-Week, Phase IIa, Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA). Arthritis Rheumatol. 2023 Feb 14. doi: 10.1002/art.42477. Epub ahead of print. PMID: 36787101.

Tags: Publications, Rheumatology

Training Stage, Program Pedigree, Degree Pathway, and Research Productivity among United States Gastroenterology Fellows

Stirrat TS, Tian T, Solanky P, Apte S, Shahrin S, Flatley M, Thiru S, Kakde S, Kanth P. Training Stage, Program Pedigree, Degree Pathway, and[...]

Response by Fonarow et al to Letter Regarding Article, “Improving Heart Failure Quality of are Over the First Twenty Years: The Get With The Guidelines-Heart Failure Program”

Tang AB, Greene SJ, Fonarow GC. Response by Fonarow et al to Letter Regarding Article, "Improving Heart Failure Quality of are Over the First Twenty[...]

Silicosis in the Artificial Stone Countertop Industry: An Official American Thoracic Society Workshop Report

Gandhi SA, Liu GY, Fazio JC, Amubieya O, Barnes H, Cavalin C, Cohen RA, Fireman E, Garcia SR, Harrison RJ, Houlroyd JL, Hua JT, Jones[...]